Sanofi (SNY) Ending Cash Balance (2009 - 2026)
Sanofi (SNY) posted Ending Cash Balance of $12.46 billion for Q3 2026, up 19.3% from $10.45 billion a year earlier and up 71.8% from the prior quarter.
Analysis
Sanofi (SNY) Ending Cash Balance (2009 - 2026) Analysis & Trends
For FY2025, Sanofi's Ending Cash Balance came in at $9 billion, up 16.3% from FY2024.
- Annual Ending Cash Balance shows a five-year compound annual growth rate of -12.1% (FY2020 to FY2025).
- In prior years, Sanofi's Ending Cash Balance was $7.74 billion in FY2024 (-19.7%), $9.64 billion in FY2023 (-29.0%), $13.58 billion in FY2022 (+18.7%) and $11.44 billion in FY2021 (-33.2%).
- The Q3 2026 figure stands as the highest quarterly Ending Cash Balance since Q2 2025.
- On a year-over-year basis, Ending Cash Balance increased in three of the last seven quarters, with growth averaging 9.2%.
- The strongest year-over-year quarter for Ending Cash Balance in the past five years was Q2 2025, with growth of 147.5%; the weakest was Q2 2026, with a decline of 59.7%.
- According to Business Quant data, Ending Cash Balance for the three prior quarters was $7.25 billion (Q2 2026), $6.35 billion (Q1 2026) and $9 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Sanofi | 59.05 Bn | 29.25 Bn | 33.35 Bn | 6.77 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 12.46 Bn |
| Jun 30, 2026 | 7.25 Bn |
| Mar 31, 2026 | 6.35 Bn |
| Dec 31, 2025 | 9.00 Bn |
| Sep 30, 2025 | 10.45 Bn |
| Jun 30, 2025 | 18.01 Bn |
| Mar 31, 2025 | 8.65 Bn |
| Dec 31, 2024 | 7.74 Bn |
| Jun 30, 2024 | 7.28 Bn |
| Mar 31, 2024 | 9.91 Bn |
| Dec 31, 2023 | 9.64 Bn |
| Jun 30, 2023 | 8.69 Bn |
| Dec 31, 2022 | 13.58 Bn |
| Jun 30, 2022 | 7.21 Bn |
| Dec 31, 2021 | 11.44 Bn |
| Jun 30, 2021 | 11.57 Bn |
| Dec 31, 2020 | 17.12 Bn |
| Jun 30, 2020 | 17.96 Bn |
| Jun 30, 2019 | 7.67 Bn |
| Dec 31, 2018 | 7.92 Bn |
API Access
Sanofi Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=SNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();